Kanagawa, Japan

Kazuaki Takami

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Fujisawa, JP (2020 - 2023)
  • Kanagawa, JP (2015 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Profile of Innovator Kazuaki Takami

Introduction: Kazuaki Takami, based in Kanagawa, Japan, is a notable inventor with a diverse portfolio of 18 patents. His contributions to the pharmaceutical industry, particularly through his work at Takeda Pharmaceutical Company Limited, highlight his commitment to advancing medical science.

Latest Patents: Among Takami's latest inventions are two significant compounds: the first is a condensed-cyclic compound aimed at providing a solution for the prophylaxis or treatment of constipation. This compound is represented by a specific formula, detailed in his patent documentation, or a salt thereof. The second invention involves heterocyclic compounds that serve as modulators of acetylcholine receptors. Similar to the first, it may also assist in alleviating constipation and is defined by a corresponding formula in the specifications.

Career Highlights: Throughout his career, Kazuaki Takami has established himself as a prominent figure in pharmaceutical innovation. His 18 patents reflect a dedication to research and development, contributing valuable solutions to pressing health concerns. His role at Takeda Pharmaceutical Company Limited exemplifies his influence within the industry.

Collaborations: In his endeavors, Takami has collaborated with esteemed colleagues, including Masaki Seto and Yoshihiro Banno. These partnerships foster a collaborative environment that enhances the potential for groundbreaking discoveries in pharmaceutical science.

Conclusion: Kazuaki Takami's innovative contributions to the field of pharmaceuticals underline the importance of research and collaboration. His work continues to pave the way for advancements that may significantly impact medical treatments, particularly in addressing gastrointestinal issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…